We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

113 hedge funds and large institutions have $809M invested in Avadel Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 34 increasing their positions, 27 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more call options, than puts

Call options by funds: $15.6M | Put options by funds: $4.96M

175% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 8

45% more capital invested

Capital invested by funds: $559M → $809M (+$250M)

26% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 27

14% more funds holding

Funds holding: 99 → 113 (+14)

2.97% more ownership

Funds ownership: 60.85% → 63.82% (+3%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

Holders
113
Holders Change
+14
Holders Change %
+14.14%
% of All Funds
1.65%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
22
Increased
34
Reduced
27
Closed
8
Calls
$15.6M
Puts
$4.96M
Net Calls
+$10.6M
Net Calls Change
+$3.01M

Top Buyers

Rank Fund Capital Flow
1
PCH
Polar Capital Holdings
United Kingdom
+$26.3M
2
Morgan Stanley
Morgan Stanley
New York
+$18.2M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$9.18M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$5.72M
5
ABG
Ally Bridge Group
New York
+$4.08M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$17.6M
2
CAC
Cowen and Company
New York
-$8.18M
3
JP Morgan Chase
JP Morgan Chase
New York
-$4.75M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$4.14M
5
Marshall Wace
Marshall Wace
United Kingdom
-$3.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
BSW
76
Buckingham Strategic Wealth
Missouri
$194K -$9.4K -800 -6%
CAN
77
Cetera Advisor Networks
California
$173K +$5.3K +451 +4%
PCM
78
Prelude Capital Management
New York
$171K +$142K +12,076 New
CLOS
79
Compagnie Lombard Odier SCmA
Switzerland
$169K – – –
EWA
80
Exencial Wealth Advisors
Oklahoma
$169K – – –
Cambridge Investment Research Advisors
81
Cambridge Investment Research Advisors
Iowa
$168K +$140K +11,921 New
UBS Group
82
UBS Group
Switzerland
$160K -$1.57K -134 -1%
CUAMC
83
China Universal Asset Management Company
China
$146K +$94.3K +8,029 +349%
Baird Financial Group
84
Baird Financial Group
Wisconsin
$141K +$117K +10,000 New
CSS
85
Cubist Systematic Strategies
Connecticut
$131K -$110K -9,338 -50%
QL
86
Quarry LP
New York
$120K +$99.8K +8,500 New
Osaic Holdings
87
Osaic Holdings
Arizona
$90.6K -$167K -14,178 -69%
WAM
88
Wolverine Asset Management
Illinois
$83.5K – – –
LFG
89
Larson Financial Group
Missouri
$56.5K – – –
Royal Bank of Canada
90
Royal Bank of Canada
Ontario, Canada
$50K – – –
Citigroup
91
Citigroup
New York
$49.8K +$10.5K +896 +34%
BNP Paribas Financial Markets
92
BNP Paribas Financial Markets
France
$39.3K +$19.1K +1,625 +140%
TRCT
93
Tower Research Capital (TRC)
New York
$36.3K -$140K -11,945 -82%
SSG
94
Summit Securities Group
New York
$34K +$28.5K +2,422 New
SPIA
95
Steward Partners Investment Advisory
New York
$32.5K – – –
Zurich Cantonal Bank
96
Zurich Cantonal Bank
Switzerland
$28.3K -$2.89K -246 -11%
ACM
97
ADAR1 Capital Management
Texas
$28.2K +$23.5K +2,000 New
NA
98
NewEdge Advisors
Louisiana
$18.4K – – –
RhumbLine Advisers
99
RhumbLine Advisers
Massachusetts
$17.7K – – –
HFM
100
Hartford Financial Management
Connecticut
$14.1K – – –
1 2 3
4
5

AVDL Hedge Fund Activity: Q4 2023 in Review

113 of the 6,864 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q4 2023, worth a combined $809M — up 45% from $559M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new AVDL positions and 8 closed out — a net gain of 14 holders — while 34 added to existing stakes and 27 trimmed.

The largest buyer was Polar Capital Holdings, adding an estimated $26.3M. The largest seller was Adage Capital Partners, cutting an estimated $17.6M.

  • 113 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q4 2023, up from 99 in Q3 2023.
  • Funds reported $809M of Avadel Pharmaceuticals stock for Q4 2023, up 45% quarter-over-quarter.
  • 22 funds opened new Avadel Pharmaceuticals positions in Q4 2023 and 8 closed out, a net change of +14 holders.
  • The largest Avadel Pharmaceuticals buyer in Q4 2023 was Polar Capital Holdings, an estimated $26.3M added.
  • The largest Avadel Pharmaceuticals seller in Q4 2023 was Adage Capital Partners, an estimated $17.6M sold.

Based on aggregated 13F filings for Q4 2023.